| Endometriosis |
1 |
1 |
| Tissue |
0 |
0.59 |
| Umbilical |
0 |
0.99 |
| Skin Cancer |
0 |
0.4 |
| Skin Metastases |
0 |
0.35 |
| CT Scan |
0 |
0.33 |
| Nodule |
0 |
0.3 |
| Metastasis |
0 |
0.27 |
| Hernia |
0 |
0.19 |
| Magnetic Resonance Imaging |
0 |
0.17 |
| Care and Maintenance of Vision |
0 |
0.16 |
| Pituitary Gland |
0 |
0.16 |
| Cataract |
0 |
0.15 |
| A-Scan Biometry |
0 |
0.1 |
| Abdomen |
0 |
0.1 |
| Biopsy |
0 |
0.1 |
| Board Certification |
0 |
0.1 |
| California |
0 |
0.1 |
| Cancer |
0 |
0.1 |
| Dermatofibroma |
0 |
0.1 |
| Fallopian Tube |
0 |
0.1 |
| Florida |
0 |
0.1 |
| Gland |
0 |
0.1 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.1 |
| Keloids |
0 |
0.1 |
| Ligament |
0 |
0.1 |
| Ovary |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Private Practice |
0 |
0.1 |
| Scan |
0 |
0.1 |
| Surgery |
0 |
0.1 |
| Uterus |
0 |
0.1 |
| Complementary and Alternative Medicine |
0 |
0.09 |
| Pain Management |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |